Matsuura; Naoko
Patent Applications and Registrations
Patent applications and USPTO patent grants for Matsuura; Naoko.The latest application filed is for "2,4- diaminopyrimidine derivatives".
- Matsuura; Naoko - Tokyo JP
- MATSUURA; Naoko - Tsukuba-shi JP
- Matsuura; Naoko - Minato-ku JP
- Matsuura; Naoko - Tsukuba JP
- Matsuura; Naoko - Ibaraki JP
- Matsuura; Naoko - Ibaraki Pref JP
- Matsuura; Naoko - Yokohama JP
| Patent | Date |
|---|---|
| Polymer electrolyte fuel cell Grant 9,711,815 - Takane , et al. July 18, 2 | 2017-07-18 |
| 2,4- Diaminopyrimidine Derivatives App 20130345180 - BAENTELI; Rolf ; et al. | 2013-12-26 |
| Polymer Electrolyte Fuel Cell App 20130330649 - Takane; Tomoyuki ; et al. | 2013-12-12 |
| 2,4-diaminopyrimidine derivatives Grant 8,431,589 - Baenteli , et al. April 30, 2 | 2013-04-30 |
| Bicyclic derivatives as CETP inhibitors Grant 8,410,275 - Kishida , et al. April 2, 2 | 2013-04-02 |
| Pyrimidine derivatives Grant 8,263,590 - Garcia-Echeverria , et al. September 11, 2 | 2012-09-11 |
| Bicyclic Derivatives As Cetp Inhibitors App 20120225874 - KISHIDA; Masashi ; et al. | 2012-09-06 |
| Bicyclic derivatives as CETP inhibitors Grant 8,232,403 - Kishida , et al. July 31, 2 | 2012-07-31 |
| Pyrimidine Derivatives App 20110201606 - Garcia-Echeverria; Carlos ; et al. | 2011-08-18 |
| 2,4- Diaminopyrimidine Derivatives App 20110172231 - BAENTELI; Rolf ; et al. | 2011-07-14 |
| 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,964,592 - Garcia-Echeverria , et al. June 21, 2 | 2011-06-21 |
| 2,4-diaminopyrimidine derivatives Grant 7,943,627 - Baenteli , et al. May 17, 2 | 2011-05-17 |
| 2,4-pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20110098280 - Garcia-Echeverria; Carlos ; et al. | 2011-04-28 |
| 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders Grant 7,893,074 - Garcia-Echeverria , et al. February 22, 2 | 2011-02-22 |
| Bicyclic derivatives as CETP inhibitors App 20090227580 - Kishida; Masashi ; et al. | 2009-09-10 |
| Pyrimidine Derivatives App 20090131436 - Imbach; Patricia ; et al. | 2009-05-21 |
| CETP inhibitors App 20090075968 - Sakaki; Junichi ; et al. | 2009-03-19 |
| 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders App 20080132504 - Garcia-Echeverria; Carlos ; et al. | 2008-06-05 |
| 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders App 20060247241 - Garcia-Echeverria; Carlos ; et al. | 2006-11-02 |
| Pyrimidine derivaties App 20060100227 - Baenteli; Rolf ; et al. | 2006-05-11 |
| Electronic device plated with gold by means of an electroless gold plating solution Grant 4,963,974 - Ushio , et al. October 16, 1 | 1990-10-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 